- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Celgene Corp. (CELG)
Index:
- Closing Price Chg: $0.00
- 52 Week High: $0.00
- 52 Week Low: $0.00
- Currency: US Dollars
- Shares Issued: 702.45m
- Volume: 0
Latest ShareCast News
Bristol Myers acquires Celgene in $74bn pharma deal
By Iain Gilbert
Date: Thursday 03 Jan 2019
(Sharecast News) - US drugmaker Bristol-Myers Squibb reached a deal to acquire biotech group Celgene on Thursday in one of the largest acquisitions ever in the history of the pharmaceuticals industry.
Juno Therapeutics surges on Celgene deal
By Michele Maatouk
Date: Monday 22 Jan 2018
(ShareCast News) - Juno Therapeutics was set to surge at the open on Monday after agreeing for Celgene to buy the shares in the biopharmaceutical group it does not already own for around $9bn in cash.
Trump calls on drug giants to boost US production, lower prices
By Alexander Bueso
Date: Tuesday 31 Jan 2017
(ShareCast News) - The new US president called on the main pharmaceuticals firms to boost their production in the US and decrease their prices.
No recent information was found.
Celgene Corp. Market Data
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 702.45m |
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN